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The objective of this research is to compare and identify effective methods for the identification of gene loci associated 
with a disease outcome in the analysis of genome-wide data.  We evaluate three methods, namely single SNP analysis, Sequence 
Kernel Association Test (SKAT) and the recently proposed Generalized Higher Criticism (GHC). The simulated data used in this 
research were constructed from a control data set in a study of Crohn's disease. True positive (TP) and false positive rate (FP) were 
evaluated under different genetic models for disease with significant thresholds adjusted for multiple hypothesis testing based on 
the permutation method.  The findings are mixed with all three methods giving similar TP rates under some disease models and 
different rates for other models.  Overall, GHC is shown to be preferable in terms of error rates but it is disadvantageous in terms 
of computational efficiency.   
 





Advances in medical science and the promise of 
innovative treatments such as gene therapy depend on accurate 
and effective statistical analysis methods for identifying target 
genetic region(s) for treatment. Single SNP analysis is a 
traditional method used to analyze the association between 
SNPs and disease by analyzing each SNP loci while logistic 
regression and chi-square test (Clarke et al., 2011; Lewis, 2002) 
are simple and effective ways to conduct the single SNP tests 
for association. Although the single SNP analysis has proven 
useful in many studies, this method faces the problem of type I 
error rate inflation and methods for correcting this, such as 
Bonferroni, are often overly conservative. An alternative to 
single SNP analysis, which groups variants into SNP-sets and 
 
jointly tests for an effect with disease outcome, is motivated by 
the possibility that there could be many variants, each with 
small individual effects and in LD with causal variant(s) (Wu 
et al., 2010). This approach is claimed to be more effective 
(Kirdwichai & Baksh, 2019; Schaid, Rowland, Tines, 
Jacobson, & Poland, 2001; Zhao et al., 2012) in identifying 
disease loci.  
Wu et al. (2010) proposed a logistic kernel machine 
model to analyze the association between SNP-set (grouping by 
gene, gen networks, pathways or haplotype block) with disease 
outcome and claimed that grouping into SNP-sets can lead to 
improving the power of the test. Wu et al. (2011) utilize this 
concept and proposed SKAT to analyze rare variant association 
with complex traits. SKAT is a supervised, flexible, compu-
tationally efficient regression method to test for association 
between common or rare variants and disease (Iuliana-Laza, 
Lee, Makarov, Buxbaum, & Lin, 2013; Lee et al., 2012). A 
crucial feature in implementing SKAT is assigning appropriate 
weights as this can have an impact on the power of the test 
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More recently the Generalized Higher Criticism 
(GHC) was proposed for testing multiple SNPs simultaneously 
in genome-wide association studies (Barnett, Mukherjee, & 
Lin, 2017). This approach extends a technique called higher 
criticism (HC) and compares the observed significant findings 
in the single SNP analysis with the expected number under the 
null while accounting for the correlation between the hypo-
thesis test statistics. It should be noted that HC has been applied 
in high-dimensional, low correlation signal detection settings 
whereas SNP-sets frequently have a low number of true 
positive associations which can be highly correlated. The GHC 
method is flexible to the correlation structure and is com-
putationally efficient, producing a p-value without the need for 
simulation of the null distribution. SKAT and GHC are 
implemented in the R packages SKAT (Lee, 2017) and GHC 
(Barnett, 2015) 
Crohn’s disease is an autoimmune disease that is 
suspected to be genetically linked with several genes being 
identified across the genome as being associated with 
chromosome 16. It's not clear which genes are responsible for 
this disease. Therefore, the simulation study in this paper uses 
genotype data on Chromosome 16 from 1,504 individuals in the 
1958 British Birth Cohort (Wellcome Trust Case and Control 
Consortium, 2007).  False positive (FP) and true positive (TP) 
rates were evaluated for the different methods with significant 
thresholds adjusted for multiple hypothesis testing using a 
permutation method. Computational efficiency is also 
evaluated. Additionally, the methods are applied to real data 
from a study (Wellcome Trust Case and Control Consortium, 




2.1 Single SNP analysis 
 
Logistic regression (Bush & Moore, 2012) is an 
extension of linear regression where the outcome of a linear 
model is transformed using a logistic function that predicts the 
probability of having case status given a genotype class. 
Suppose that the possible genotypes at a particular locus are 
CC, CT, and TT and suppose that C is the rarer of the two alleles 
C and T. The additive genetic model then corresponds to TT = 
0, CT = 1, and CC = 2, respectively. 
Let P
ij
 be the probability of disease for this indi-
vidual. The logistic regression model is 
 




 is an intercept term, 𝛼′ is a vector of regression 
coefficients for the q  covariates,  is the 
covariate matrix,  is a vector of regression coefficients for 
p  observed variants, and T
ij
 in a genotype for the j th  SNP             
on the ith  individual.    
Here,  corresponds to the null hypothesis of lack of 
association between the j th  SNP and disease. In this research, 
the additive model is used in the simulations and assumed in the 
analysis of the WTCCC data, but the single SNP analysis is done 
using a logistic regression model. Logistic regression is a more 
efficient, but asymptotically equivalent, alternative to the 
Pearson's c
2
 test for analyzing this type of study data.  
 
2.2 Sequence Kernel Association Test (SKAT) 
 
A key feature of SKAT is that it tests for the joint 
effects of multiple variants in a region of the genome on disease. 
Regions can be defined by genes, haplotype block, principal 
component analysis, or sliding window etc. For each region, 
SKAT analytically calculates a p-value for association (Lettre, 
Lange, & Hirschhorn, 2007; Lewis, 2002; Wu et al., 2010).  The 
theory underlying the test procedure can be viewed within the 
kernel machine regression framework. Consider the 
semiparametric logistic regression model for the i- th subject 
in a study (i=1,…, n) 
 
𝑙𝑜𝑔𝑖𝑡𝑃(𝑦𝑖 = 1) = 𝛼0 + 𝛼




 is a binary disease outcome taking values 0 (disease-
free) or 1 (disease), a
0
 is an intercept term, 𝛼′ is the vector of 
regression coefficients for the covariates  and T
i
 are the 
observed variants and is related to disease through a 
nonparametric function      which is assumed to lie in a 
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functional space generated by a positive semidefinite kernel 
function           Under this model, the null hypothesis of no 
association between disease and gene region H
0
: h(T )= 0can 
be tested by assuming the             vector  
for the genetic effects of the n  subjects follow a distribution 
with mean  0  and covariancetK , where t  is a variance 
component that indexes the effect of the variants.  
The semiparametric logistic regression model in 
equation (1) is equivalent (Wu et al., 2011) to 
 
𝑙𝑜𝑔𝑖𝑡𝑃(𝑦𝑖 = 1) = 𝛼0 + 𝛼
′𝑪𝑖 + 𝛽
′𝑻𝑖 ,                                   (3) 
 
where 𝜷′ = (𝛽1, 𝛽2, … , 𝛽𝑝) is a vector of regression coefficients 
for the p observed variants in the gene region with each  𝛽𝑗  
following an arbitrary distribution with mean of zero and a 
variance of w
j
t,  for  variance component t  and where w j  is 
a pre-specified weight for variant j. The null hypothesis 
 is equivalent to the hypothesis H0 :t = 0, which 
may be tested with a variance-component score test statistic 
 
𝑆 = (𝒀 − ?̂?)′𝑲(𝒀 − ?̂?)                                                        (4) 
 
where ,  is the predicted mean of Y= (y1,…yn)’ 
under H0  that is ?̂? = 𝑙𝑜𝑔𝑖𝑡
−1(?̂?0 + 𝐶?̂?),â
0
 and  are 
estimated under the null model by regressing  on the 
covariate  and 𝑻 = [𝑇1, . . . , 𝑇𝑛] is an             matrix with 
elements variant j  of individual i , and  = diag w1 , ..., wp( ) 
contains the weights of the p  variants. SKAT uses the 
variance-component score test statistic to test the null of no 
genetic effect but exploits the semiparametric regression 
approach in computing K . The form for K  used by SKAT is 
an                 symmetric matrix with elements                   that 
measures genetic similarity between the i- th and  
subjects     in    the    study.    The    weighted    linear     kernel  
 
                                       is used in this study.  
 
Choosing an appropriate weight is very important in 
SKAT because a good choice of weights can improve the power 
of the test. Weight functions can be specified in the SKAT 
package in R. In this paper we select four weights based on the 













<1; a,b>0,                            (5) 
 
where B denotes the beta function, a  and b are prespecified 
scale and shape parameters and x
j
 is the estimated minor allele 
frequency (MAF) for SNP j  using all cases and controls.  First 
selected is the default weight in the SKAT package
Beta( x
j
:1,25 ) which, by choosing a  small and b large, 
substantially up-regulates rare variants and down-regulates 
common variants (Wu et al., 2011). Second is the Madsen and 
Browning weight, defined as Beta( x
j
:0.5,0.5 ), which 
corresponds to wj = 1 / MAFj(1- MAFj ) ; that is w
j
 the 
inverse of the variance of the genotype marker j. The Madsen 
and Browning weight can pick up signals from both common 
and rare variants but is thought to suffer from low power. The 
third option w
j
= 1 / q
j
, which we call inverse mean, is 
equivalent to Beta( x j :0.5,1). The final option considered in 
this paper is Beta( x j :10,10 ) , which gives the appearance of a 
symmetrical distribution similar to the normal distribution. 
These weight functions are illustrated in Figure 1. (Sookkhee, 




Figure 1. Weight functions use in SKAT analysis 
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2.3 Generalized Higher Criticism (GHC) 
 
While SKAT uses the observed variants in a gene 
region to construct a joint score test statistic for association with 
disease outcome, GHC (Barnett, 2018) tests gene regions for 
association by using single variant statistics and their 
correlation matrix to construct a new test statistic and its 
distribution. Consider the parametrization of 𝑃(𝑦𝑖 = 1) for the 
j-th variant in a set of p variants, 
 
𝑙𝑜𝑔𝑖𝑡𝑃(𝑦𝑖 = 1) = 𝛼0 + 𝛼
′𝑪𝑖 + 𝛽𝑗𝑇𝑖,𝑗 ,                                             (6) 
 
where 𝛽𝑗  is the effect of the j-th variant and 𝑇𝑖,𝑗 is the observed 
j-th variant on the i-th subject, and the other terms are as in the 
previous section. The GHC approach exploits the fact that 
while p  might be large in the test of the global null 𝐻0: 𝛽 =
𝟎,  in a genetic construct variants are likely to be correlated and 
generally only a small subset of variants are signals for 
association.  In other words, a sparse set of the 𝛽′ =
(𝛽1 , 𝛽2 , … , 𝛽𝑝) are not zero. GHC aims to account for both 
sparse signals and correlation among SNPs when combining 
individual marker test statistics. 
Let 𝑻𝒋
′ = (𝑇1,𝑗 . . . 𝑇𝑛,𝑗) be the vector of observed 
variants at the j-th marker, Y= (y1,…yn)’x be the observed 
disease status and ?̂? = (𝜇1̂, . . . , 𝜇?̂?)
′ be the predicted mean 
for Y under the assumption of no genetic effect. The score test 









where 𝑃 = 𝑊 − 𝑊𝐶(𝐶 ′𝑊𝐶)−1𝐶 ′𝑤 and 𝑊 = 𝑑𝑖𝑎𝑔{𝜇1̂(1 −
𝜇1̂) … , 𝜇?̂?  (1 − 𝜇?̂?)}. These individual variant test   statistics    
are    asymptotically    jointly    distributed    as  
, where the ( i,k )th  component of  is 








.   
Define S( t ) by 
                                                        (9) 
 






𝑆(𝑡) − 2𝑝(1 − 𝜙(𝑡))
√𝑣𝑎?̂?(𝑆(𝑡)
}, 
               
where𝜙(𝑡) is the standard normal distribution function and 
𝑣𝑎?̂?(𝑆(𝑡)) is calculated accounting for the correlation between 
the 𝑍′𝑗𝑆. The p-value  
 
 
𝑃(𝐺𝐻𝐶) ≥ 𝑇𝐺𝐻𝐶 
              
is also calculated accounting for this correlation. The algorithm 
behind this approach is implemented in the R package GHC. 
 
2.3 Multiple hypothesis testing 
 
For m independent tests and the rejection level α for 
each test, the probability of falsely rejecting at least one true 
null hypothesis, otherwise known at the family-wise error rate 
(FWER), increases in such a way that for even a moderate 
number of tests we will almost surely incorrectly reject at least 
one true null hypothesis. In fact, the probability at least one type 
I error in p tests is 1 − (1 − 𝛼)𝑚. As shown in Figure 2, the 
probability at least one type I error gets close to 1 even for a 




Figure 2. Probability of at least one false positive finding for different 
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  The simplest method for controlling the FWER is 
Bonferroni correction. An alternative way to find the appro-
priate threshold is the permutation method. This method is an 
empirical method that calculates the p-value by using the 
observed test statistic value in the permuted distributed of test 
statistics under the null model. In this research, 10,000 
replicates were used for computing the multivariate sampling 
distribution under the null hypothesis with no gene effect and 
to establish significance thresholds giving a type I error close 
to 0.05.  
Simulation results of single SNP analysis, SKAT-
normal weight and GHC test under the null model of no gene 
effect in Table 1 confirms that that Bonferroni adjustment leads 
to a type I error that is much lower than the desired level and 
therefore Bonferroni correction is conservative and con-
stringent. Considering the Type I error rates based on the new 
thresholds, shown in Table 1, it’s clear that in all cases the 
nominal type I error of 0.05 is achieved using the Permutation 
threshold. Therefore, the permutation thresholds are selected 
for comparing the efficiency of the single SNP analysis, SKAT, 
and GHC. 
 
2.4 The data and disease model simulation 
 
The genotype data used in this simulation are 13,479 
SNPs on Chromosome 16 from 1,504 unaffected individuals in 
the WTCCC study of Crohn's disease. Using 3,008 haplotypes 
constructed from the 1,504 genomes, new genotype data were 
generated and assigned disease status based on 2 disease SNPs 
both of which have very high MAF's and are highly correlated 
with other SNPs on their respective genes. The first SNP 
rs3789038 is located at position 50711672bp in gene HMOX2 
and has MAF equal to 0.31. The second,  SNP  rs3785142  has  
 
Table 1. Achieved type I error of single SNP, SKAT analysis and 






   
Single SNP analysis 0.033 0.059 
SKAT Default 0.040 0.057 
SKAT Madson & Browning 0.031 0.055 
SKAT Inverse mean 0.033 0.059 
SKAT Normal 0.040 0.055 
GHC method 0.039 0.057 
   
MAF equal 0.48 and is located at position 50753236bp in gene 
CYLD (Sookkhee, Baksh, & Kirdwichai, 2017). The model for 
one disease SNP used to generate disease status is 
   













,                                  (12) 
 
where T  is the number of copies of the rare allele of the disease 
SNP, a 0  is a pre-specified baseline relative risk of disease and 
b
1
 is the gene effect, which in this study was set equal to 0.2. 





























 .                                 (13) 
 
This model assumes the two disease SNPs act linearly 
on the logit scale and two situations are investigated. The first 
is for gene effect b
1
= 0.1 and b
2
= 0.2 while in the second case 
the gene effects are fixed at b
1
= 0.2 and b
2
= 0.1. 
The procedure in simulating the data is shown in 
Figure 3. The 1,504 genotypes are first separated to construct 
3,008 haplotypes as the initial data. The haplotypes are next 
coded to 0 (major allele) and 1 (minor allele) and used to 
construct pairs of parental genotypes using randomly selected 
haplotypes. Each pair of parental genotypes are then used to 
construct the genotype of an individual in the study. Disease 
status was then determined via the disease probability given by 
equation 12 in the case of one disease SNP and by equation 13 
in the case of two disease SNPs.  
 
3. Simulation Study  
 
In this research, simulation results are presented from 
single SNP analysis, SKAT, and GHC test for two cases. The 
simulation result in the first case is one disease SNP and the 
second is two disease SNPs. A total of 1,500 replicate studies, 
each consisting 3,000 cases and 3,000 controls are simulated 
and, for each study, a count is made of the number of SNPs 
incorrectly identified as significantly associated with disease 
(false positive rate) and whether the disease SNP is correctly 
identified (true positive rate) by the single SNP, SKAT and 
GHC test described above.  
























                                        
Figure 3.     The procedure in the generating simulated data 
 
3.1 The simulation results of one disease SNP 
 
The TP and FP rates of single SNP, SKAT normal, 
and GHC test of rs3789038 as disease SNP with gene effect 
size b
1
= 0.2 are provided in Table 2. The FP rate of the single 
SNP analysis is seen at 0.00105 to be roughly at least 14 and 11 
times lower than the SKAT normal and GHC test, respectively. 
But this comes at the lower TP rate of 0.71. When considering 
the FP rate, the result shows that the GHC test gives the lowest 
FP. 
The TP and FP rates of the single SNP and SKAT 
analyses with rs3785142 as disease SNP with gene effect size 
b
1
 = 0.2. The FP rate of the single SNP analysis is 0.00132 and 
TP rate is 0.89 showing high the TP and FP. When we 
considered SNP-set analysis, the efficient model of SKAT is 
SKAT normal showing the TP as 0.92 more than GHC at least  







Step 2: Select random the haplotype for the father and mother and bring together to  
                construct the new individual 
 
Father 1 0 0 0 0 0 1 
                                                     + 
Mother 0 0 0 1 0 0 1 
     =        
Individual  1 0 0 1 0 0 2 
 







Step 3: Define the disease SNP 
                                                         Disease SNP 
 
 SNP1 SNP2 SNP3 SNP4 SNP5 SNP6 SNP7 
        
Individual 1 0 0 0 1 0 0 2 
Individual 2 0 0 2 1 0 1 0 
Individual 3 1 0 0 0 0 0 0 
Individual 4 1 2 1 0 0 1 1 
        
Individual 6000 1 0 1 1 1 2 1 
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Table 2. The TP and FP rates of single SNP, SKAT, and GHC test 
with rs3789038 and rs3785142 as disease SNP and effect 
size b
1
 = 0.2 
Method 
Disease SNP rs3789038 Disease SNP rs3785142 
FP rate TP rate FP rate TP rate 
     
Single SNP 
analysis 
0.00105 0.71 0.00132 0.89 
SKAT default 0.00154 0.80 0.00209 0.00 
SKAT Madsen & 
Browning 
0.01073 0.86 0.03705 0.65 
SKAT inverse 
mean 
0.00981 0.86 0.02734 0.57 
SKAT normal 0.00939 0.85 0.04867 0.92 
GHC 0.00096 0.82 0.00075 0.86 
     
 
6 times while the FP rate of GHC is lower than all method. An 
appropriate weight in this case is the normal and this is 
confirmed by the simulation results. 
 
3.2 The simulation results of two disease SNPs 
 
The comparisons of TP and FP rates for single SNP, 
SKAT and GHC test based on the permutation threshold were 
provided in Table 2. It was computed from 1,500 replicates 
with a gene effect size for disease SNP rs3789038 of b
1
= 0.2 
and effect size for rs3785142 of b
2
= 0.1. Here the single SNP 
method is found to have the lowest TP rate (0.85) and FP rate 
(0.00220). The TP is consistent with the findings in Table 2. 
We found that when we defined two disease SNP the FP from 
SKAT and GHC test gave a high TP and FP. SKAT gave higher 
FP than GHC test while the rates were close to TP.  
When considering the gene effect size for disease 
SNP rs3789038 of b
2
 = 0.1 and effect size for rs3785142 of b
1
 
= 0.2, the FP rate of single SNP analysis is the lowest while the 
TP is quite high. SKAT and GHC test give a high TP and high 
FP.  Totally, the efficient model of SKAT is SKAT normal 
because this weight can pick up signals from both common and 
rare variants. The efficient SKAT normal was chosen as a 
representative of the SKAT method in applying to real data. 
 
4. Real Data Application  
 
  The three methods were evaluated in the previous 
section can be applied to real data to define the locate of SNP 
or region that cause the disease. The data set used has 13,479 
SNPs on Chromosome 16 comprise 2,005 cases and 1,500 
controls of Crohn’s disease studies. The result showed the 
SNPs which were declared as significant by Single SNP 
analysis, SKAT normal, and GHC in Table 3. The example of 
horizontal line of permutation threshold for declaring 
significant of Single SNP analysis and SNP-set method are 
presented in Figure 4. 
The genes that were declared as significant by three 
methods which single SNP analysis, SKAT and GHC are 
shown in Table 4. Single SNP analysis found eight significant 
regions. SKAT normal found four regions and the GHC method 
found four region.  
 
5. Discussion and Conclusion 
 
The findings confirm that the single SNP analysis is 
robust in producing an equal FP value when we change the 
disease SNP rs3789038 to rs3785142. On the other hand, the 
efficiency of the SKAT analysis for genome-wide association 
analysis is highly dependent on the disease-causing SNPs. 
Determining the disease SNP are affects TP and FP rate. We 
may have to consider the value of MAF, the correlation 
between SNP in the gene. The important thing in SKAT is the 
choice of weight and this must be carefully selected. It is 
necessary to find the appropriate weight for the data being 
studied by tuning the appropriate parameters to get a powerful 
test. Incorrect weight and data misalignment may  lead  to  low 
 
Table 3. The TP and FT rates of single SNP and SKAT analysis with 
rs3789038 and rs3785142 as disease SNPs and respective 
effect sizes of b
1
= 0.2 and b
2
 = 0.1. and effect sizes of b
1
= 0.1 and b
2




= 0.2  and b2 = 0.1 b
1
= 0.1 and b
2
 = 0.2 
FP rate TP rate FP rate TP rate 
     
Single SNP 
analysis 
0.00220 0.85 0.00270 0.94 
SKAT default 0.00344 0.92 0.00482 0.38 
SKAT Madsen 
& Browning 
0.04139 0.93 0.06329 0.80 
SKAT inverse 
mean 
0.03321 0.94 0.05624 0.74 
SKAT normal 0.03329 0.94 0.04820 0.93 
GHC 0.01716 0.93 0.02308 0.96 
     









Figure 4. The horizontal line of the permutation threshold for 
declaring significance of Single SNP analysis (a) and SNP-
set method (b) 
 
Table 4. Genes on Chromosome 16 declared as significant by Single 
SNP analysis, SKAT and GHC method using the permu-






    
1 LMF1 - - 
2 RBFOX1 - - 
3 - LOC646828 - 
4 XPO6 - - 
5 SMG1P5 SMG1P5 SMG1P5 




7 Intron Gene 173 - Intron Gene 
173 








9 C16ORF70 - - 
    
 
 
 test power. GHC results were more robust when the disease 
SNP were changed. In the case one disease SNP, GHC gave a 
small FP while TP was close to that of the other two methods. 
When considering the test power, GHC is better than the other 
two methods. But it is difficult to specify which method is 
better because the meaning of an effective model covers many 
issues including the power of the test and computational 
efficiency. We find that the GHC test is a statistical method for 
testing the SNP-set suitable for the SNP-set containing a finite 
set of the correlated marker. These SNP data have no variation 
so the covariance matrix cannot be calculated. It is necessary to 
remove the no variation SNP from the data set. In the process 
of checking and deleting no variation data, the analysis takes a 
lot of time when compared with the single SNP and SKAT test, 
so that while GHC is shown to be preferable in terms of error 
rates, it is disadvantageous in terms of computational 
efficiency. It is obvious that the testing power of the three 
methods are equal, but the time it takes to test the SKAT normal 
is minimal as shown in Table 5. 
In the section of real data analysis, all of the methods 
found that many regions are significant Especially, Region 4 
contributed the intron gene 174, NOD2 and CYLD gene, 
corresponding to many pieces of research that found NOD2 is 
identified as a highly significant variant in Crohn’s disease 
(Michail, Bultron, & DePaolo, 2013). Sidiq and Yoshihama 
(2016) said that NOD2 plays a key role in the regulation of 
microbiota in the small intestine and is the strongest risk factor 
in ileal Crohn's disease. It is confirmed that NOD2 is one of the 
most critical genetic factors causing the disease. In this 
research, NOD2 was found in all of the methods. In this 
situation, SKAT has the advantage when compared to the other 
methods in terms of providing the same results but taking less 
time. We expect this method will help to get accurate and fast 
answers in tests to find genes region that affect other diseases 
as well. 
 
Table 5. Processing time for testing in each method  
Method 
Average time per 
one replicate 
Total time (hours) 
   
Single SNP 
analysis  
6 minutes 150 H (6.25 days) 
SKAT normal  4 minutes 100 H (4.16 days) 
GHC  30 minutes 750 H (31.25 days) 
   
 
 
Currently, there are many genomic datasets that need 
to be analyzed to yield fast, accurate and efficient answers. For 
large datasets and high dimensional data, the SNP-set method 
such as SKAT and GHC test is an interesting tool in the 
repertoire of statistical analysis methods with the advantage 
that it is potentially powerful and provides the correct 
assumptions. For SKAT, this paper only considered the 
weighted linear kernel; planned further work will evaluate the 
use of different kernels within the genomic setting. Although 
the two methods for analysis the SNP-set offer more advantage 
than the single SNP analysis in terms of computation, the high 
false positive rate in the SKAT method remains a concern.  
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